Merck Sharp & Dohme LLC recalls Noxafil Powdermix
- Recalling company
- Merck Sharp & Dohme LLC
- Product
- Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
- Reason
- Presence of particulate matter: potential presence of metal particulates in the product.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Dec 12, 2025
- Reported
- Dec 31, 2025
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 845 kits
- Lot / codes
- Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026
- Company location
- Wilson, NC
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0242-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0242-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.